EUVIMEDEUVIMED entdecken
Crossref

Repeated intravenous infusion of mesenchymal stem cells enhances recovery of motor function in a rat model with chronic spinal cord injury

Kota Kurihara, Masanori Sasaki, Hiroshi Nagahama, Hisashi Obara, Ryunosuke Fukushi, Ryosuke Hirota, Mitsunori Yoshimoto, Atsushi Teramoto, Jeffery D Kocsis, Toshihiko Yamashita, Osamu Honmou

Brain Research · 2023-10 · 1817 · 148484

DOI: 10.1016/j.brainres.2023.148484 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2023-10. Verfasst von Kota Kurihara und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556…. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord injury (SCI) can cause paralysis with a high disease burden with limited treatment options. A single intravenous infusion of mesenchymal stem cells (MSCs) improves motor function in rat SCI models, possibly through the induction of axonal sprouting and remyelination. Repeated infusions (thrice at weekly intervals) of MSCs were administered to rats with chronic SCI to determine if multiple-dosing regimens enhance motor improvement. Chronic SCI rats were randomized and infused with vehicle (vehicle), single MSC injection at week 6 (MSC-1) or repeatedly injections of MSCs at 6, 7, and 8 weeks (MSC-3) after SCI induction. In addition, a single high dose of MSCs (HD-MSC) equivalent to thrice the single dose was infused at week 6. Locomotor function, light and electron microscopy, immunohistochemistry and ex vivo diffusion tensor imaging were performed. Repeated infusion of MSCs (MSC-3) provided the greatest functional recovery compared to single and single high-dose infusions. The density of remyelinated axons in the injured spinal cord was the greatest in the MSC-3 group, followed by the MSC-1, HD-MSC and vehicle groups. Increased sprouting of the corticospinal tract and serotonergic axon density was the greatest in the MSC-3 group, followed by MSC-1, HD-MSC, and vehicle groups. Repeated infusion of MSCs over three weeks resulted in greater functional improvement than single administration of MSCs, even when the number of infused cells was tripled. MSC-treated rats showed axonal sprouting and remyelination in the chronic phase of SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesMesenchymal Stem CellsMesenchymal Stem Cell TransplantationRatsAnimalsInfusions, IntravenousDiffusion Tensor ImagingSpinal CordPyramidal TractsRecovery of Function

Stichwörter der Autor:innen

ChronicMesenchymal stem cellsRatSpinal cord injury

Autor:innen und Institutionen

  • Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan; Department of Orthopaedic Surgery, Sapporo Medical University…
  • Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan; Department of Neurology, Yale University School of Medicine,…
  • Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan; Division of Radioisotope Research, Biomedical Research, Educa…
  • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
  • Department of Neurology, Yale University School of Medicine, New Haven, CT 06510, USA; Department of Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA; Center for Neuroscience and Regeneration R…

Zitieren

APA

Kurihara, K., Sasaki, M., Nagahama, H., Obara, H., Fukushi, R., Hirota, R., Yoshimoto, M., Teramoto, A., Kocsis, J. D., Yamashita, T., & Honmou, O. (2023). Repeated intravenous infusion of mesenchymal stem cells enhances recovery of motor function in a rat model with chronic spinal cord injury. Brain Research, 1817, 148484. https://doi.org/10.1016/j.brainres.2023.148484

Vancouver

Kurihara K, Sasaki M, Nagahama H, Obara H, Fukushi R, Hirota R, et al. Repeated intravenous infusion of mesenchymal stem cells enhances recovery of motor function in a rat model with chronic spinal cord injury. Brain Research. 2023;1817:148484. doi:10.1016/j.brainres.2023.148484

BibTeX
@article{Kurihara2023,
  author = {Kurihara, Kota and Sasaki, Masanori and Nagahama, Hiroshi and Obara, Hisashi and Fukushi, Ryunosuke and Hirota, Ryosuke and Yoshimoto, Mitsunori and Teramoto, Atsushi and Kocsis, Jeffery D and Yamashita, Toshihiko and Honmou, Osamu},
  title = {Repeated intravenous infusion of mesenchymal stem cells enhances recovery of motor function in a rat model with chronic spinal cord injury},
  journal = {Brain Research},
  year = {2023},
  volume = {1817},
  pages = {148484},
  doi = {10.1016/j.brainres.2023.148484}
}
Kostenlos starten →